• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antigenics Inc/CO

+ Add to Watchlist

ANTI:US

Price not available for ANTI:US

Snapshot for Antigenics Inc/CO (ANTI)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for ANTI

No chart data available.
  • ANTI:US
  • 1M
  • 1Y
0.0000
Interactive ANTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANTI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANTI

No data available

Company Profile & Key Executives for ANTI

Antigenics Inc. researches and develops therapies for cancer, infection, and immune and degenerative disorders. The Company's technologies include immune modulators and liposomal formulations of small molecule drugs. Antigenics licenses its immune enhancement technologies to pharmaceutical partners.

More Company Profile & Key Executives for ANTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil